Clear Investment Research’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-800
Closed -$9.18K 254
2025
Q2
$9.18K Hold
800
0.01% 163
2025
Q1
$8.94K Hold
800
0.01% 159
2024
Q4
$7.46K Hold
800
0.01% 164
2024
Q3
$7.17K Hold
800
0.01% 163
2024
Q2
$9.68K Hold
800
0.01% 152
2024
Q1
$17.4K Hold
800
0.02% 140
2023
Q4
$20.9K Hold
800
0.03% 145
2023
Q3
$17.8K Hold
800
0.03% 116
2023
Q2
$22.8K Hold
800
0.04% 113
2023
Q1
$27.7K Hold
800
0.05% 102
2022
Q4
$30K Hold
800
0.06% 92
2022
Q3
$25K Hold
800
0.05% 98
2022
Q2
$30K Hold
800
0.07% 86
2022
Q1
$36K Hold
800
0.07% 89
2021
Q4
$42K Hold
800
0.06% 87
2021
Q3
$38K Hold
800
0.06% 87
2021
Q2
$42K Buy
+800
New +$43K 0.07% 80
2019
Q4
Sell
-8
Closed 390
2019
Q3
$0 Hold
8
﹤0.01% 390
2019
Q2
$0 Hold
8
﹤0.01% 390
2019
Q1
$1K Hold
8
﹤0.01% 206
2018
Q4
$1K Hold
8
﹤0.01% 196
2018
Q3
$1K Buy
+8
New +$543 ﹤0.01% 208
2017
Q2
Sell
-100
Closed -$8K 61
2017
Q1
$8K Buy
+100
New +$8.39K 0.01% 34

Other funds holding WBA

Clear Investment Research's WBA Position: Q3 2025 in Review

Clear Investment Research sold out of Walgreens Boots Alliance (WBA) in Q3 2025, closing a stake of 800 shares — an estimated $9.18K sold.

Clear Investment Research first reported a position in WBA in Q1 2017 and held it in 23 quarters. The position peaked at $42K in Q4 2021. 9 funds tracked by Wall St. Rank hold WBA as of Q3 2025.

  • Clear Investment Research reported no remaining Walgreens Boots Alliance position as of Q3 2025 after selling out during the quarter.
  • Clear Investment Research sold 800 Walgreens Boots Alliance shares in Q3 2025, an estimated $9.18K.
  • Clear Investment Research first reported a position in Walgreens Boots Alliance in Q1 2017 and held it in 23 quarters.
  • Clear Investment Research's Walgreens Boots Alliance position peaked at $42K in Q4 2021.
  • 9 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q3 2025.

Based on Clear Investment Research's 13F filing for Q3 2025, filed 7 Nov 2025.